Participation of the L-arginine-nitric oxide-cyclic GMP-ATP-sensitive K+ channel cascade in the antinociceptive effect of rofecoxib

European Journal of Pharmacology

Volumn 484, Issue 2-3, 2004, Pages 193-199

  Déciga Campos, Myrna ^a   López Muñoz, Francisco J ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Cyclooxygenase; Nitric oxide (NO); Rofecoxib

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATE; ANTINOCICEPTIVE AGENT; ARGININE; CYCLIC GMP; CYCLOOXYGENASE 2 INHIBITOR; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; ROFECOXIB; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HINDLIMB; KNEE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 1642464885     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.021     Document Type: Article

References (37)

1. Aley K.O., Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. J. Neurosci. 19:1999;2181-2186.
2. Aley K.O., McCarter G., Levine J.D. Nitric oxide signalling in pain and nociceptor sensitisation in the rat. J. Neurosci. 18(17):1998;7008-7014.
3. + channels in the peripheral antinociceptive effect induced by dipyrone. Eur. J. Pharmacol. 444:2002;47-52.
4. Amin A.R., Attur M., Patel R.N., Thakker G.D., Marshall P.J., Rediske J., Stuchin S.A., Patel I.R., Abramson S.B. Superinduction of cyclo-oxigenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide. J. Clin. Invest. 99(6):1997;1231-1237.
5. + channels. Science. 247:1990;852-854.
6. + channels. Am. J. Physiol. 273:1997;H76-H83.
7. Covino B.G., Dubner R., Gybels J., Kosterlitz H.W., Liebeskind J.C., Sternbach R.A., Vyclicky L., Yamamura H., Zimmermann M. Ethical standards for investigations of experimental pain in animals. Pain. 9:1980;141-143.
8. Cunha F.Q., Texeira M.M., Ferreira S.H. Pharmacological modulation of secondary mediator systems - cyclic AMP and cyclic GMP - on inflammatory hyperalgesia. Br. J. Pharmacol. 127:1999;671-678.
9. Chan C.C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Ford-Hutchinson A.W., Forrest M.J., Gauthier J.Y., Gordon R., Gresser M., Guay J., Kargman S., Kennedy B., Leblanc Y., Leger S., Mancini J., O'Neill G.P., Oullet M., Patrick D., Percival D., Perrier H., Prasit P., Rodger I., Tagari P., Therien M., Vickers P., Visco D., Wang Z., Webb J., Wong E., Xu J.L., Young R.N., Zamboni R., Riendeau D. Rofecoxib [Vioxx; MK-0966; 4-[4′-methylsulfonylphenyl]3-phenil-2-(5H)-furanone]; a potent and orally active cyclooxygenase-2-inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290:1999;551-560.
10. Duarte I.D.G., Ferreira S.H. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway. Mediat. Inflamm. 9:2000;25-30.
11. Duarte I.D.G., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 186:1990;289-293.
12. 2+-dependent process. Prostaglandins. 18:1979;179-190.
13. Na by PKC and PKA and their role in PGE2-induced sensitisation of rat sensory neurones in vitro. J. Neurosci. 18:1998;10345-10355.
14. Granados-Soto V., Flores-Murrieta F., Castañeda-Hernández G., López-Muñoz F.J. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur. J. Pharmacol. 277:1995;281-284.
15. Granados-Soto V., Rufino M.O., Lopes L.D.G., Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340:1997;177-180.
16. Habib A.C., Bernard C., Lebret M., Creminon C., Esposito B., Tedgui A., Maclouf J. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J. Inmunol. 158(8):1997;3845-3851.
17. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
18. Kawabata A., Manabe S., Manabe Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112:1994;547-550.
19. + channel pathway in the antinociceptive action of ketorolac. Eur. J. Pharmacol. 426:2001;39-44.
20. López-Muñoz F.J., Salazar L.A., Castañeda- Hernández G., Villarreal J.E. A new model to assess activity: pain-induced functional impairment in the rat (PIFIR). Drug Dev. Res. 28:1993;169-175.
21. López-Muñoz F.J., Castañeda-Hernández G., Torres-López J.E., Picazo Y.F., Flores-Murrieta F.J., Granados-Soto V. Differences in the mechanism of antinociceptive action of non-steroidal anti-inflammatory drugs in the rat. Pharm. Sci. 2:1996;189-190.
22. Lorenzetti B.B., Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurones contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm. Res. 45(6):1996;308-311.
23. Luo Z.D., Cizkova D. The role of nitric oxide in nociception. Curr. Rev. Pain. 4:2000;459-466.
24. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test. Pain. 54:1993;291-300.
25. Nakamura A., Fujita M., Shiomi H. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia. Br. J. Pharmacol. 117:1996;407-412.
26. Nozaki-Taguchi N., Yamamoto T. The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation. Anesth. Analg. 86:1998;367-373.
27. Prado W.A., Schiavon V.F., Cunha F.Q. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur. J. Pharmacol. 441(1-2):2002;57-65.
28. + channels. Br. J. Pharmacol. 129:2000;110-114.
29. Sandrini M., Vitale G., Pini A. Effect of rofecoxib on nociception and the serotonin system in the rat brain. Inflamm. Res. 51:2002;154-159.
30. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90(15):1993;7240-7244.
31. Sluka K.A., Rees H., Chen P.S., Tsurouka M., Willis W.D. Capsaicin-induced sensitisation of primate spinothalamic tract cells is prevented by a protein kinase C inhibitor. Brain Res. 772:1997;82-86.
32. Smith J.A.M., Amagasu S.M., Eglen R.M., Hunter J.C., Bley K.R. Characterisation of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol. 124:1998;513-523.
33. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol. 400:2000;67-71.
34. Sousa A.M., Prado W.A. The dual effect of a nitric oxide donor in nociception. Brain Res. 897:2001;9-19.
35. Tonussi C.R., Ferreira S.H. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitisation. Eur. J. Pharmacol. 251:1994;173-179.
36. Ventura-Martínez R., Díaz R.I., Hernández G.P., Domínguez R.A., Salazar L.A., Cabré F., López-Muñoz F.J. Role of COX-1 and COX-2 synthesised prostaglandins in a rat model of arthritic pain. Drug Dev. Res. 51:2000;253-259.
37. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.